These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15138435)

  • 1. Effects of nicotine on cognitive deficits in schizophrenia.
    Harris JG; Kongs S; Allensworth D; Martin L; Tregellas J; Sullivan B; Zerbe G; Freedman R
    Neuropsychopharmacology; 2004 Jul; 29(7):1378-85. PubMed ID: 15138435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking history and nicotine effects on cognitive performance.
    Ernst M; Heishman SJ; Spurgeon L; London ED
    Neuropsychopharmacology; 2001 Sep; 25(3):313-9. PubMed ID: 11522460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
    Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
    Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine-haloperidol interactions and cognitive performance in schizophrenics.
    Levin ED; Wilson W; Rose JE; McEvoy J
    Neuropsychopharmacology; 1996 Nov; 15(5):429-36. PubMed ID: 8914115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between nicotine-abstinent smokers and non-smokers in terms of visuospatial attention and inhibition before and after single-blind nicotine administration.
    Logemann HN; Böcker KB; Deschamps PK; Kemner C; Kenemans JL
    Neuroscience; 2014 Sep; 277():375-82. PubMed ID: 25050819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine effects on brain function and functional connectivity in schizophrenia.
    Jacobsen LK; D'Souza DC; Mencl WE; Pugh KR; Skudlarski P; Krystal JH
    Biol Psychiatry; 2004 Apr; 55(8):850-8. PubMed ID: 15050867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
    Chan PY; Davenport PW
    J Appl Physiol (1985); 2010 Mar; 108(3):662-9. PubMed ID: 20056851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV; Petros T
    Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?
    Quisenaerts C; Morrens M; Hulstijn W; de Bruijn E; Timmers M; Streffer J; De la Asuncion J; Dumont G; Sabbe B
    Psychopharmacology (Berl); 2014 Feb; 231(3):543-50. PubMed ID: 24022237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.
    Drusch K; Lowe A; Fisahn K; Brinkmeyer J; Musso F; Mobascher A; Warbrick T; Shah J; Ohmann C; Winterer G; Wölwer W
    Eur Arch Psychiatry Clin Neurosci; 2013 Sep; 263(6):519-27. PubMed ID: 23081705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine reduces antisaccade errors in task impaired schizophrenic subjects.
    Larrison-Faucher AL; Matorin AA; Sereno AB
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):505-16. PubMed ID: 15093958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks.
    Poltavski DV; Petros TV; Holm JE
    Pharmacol Biochem Behav; 2012 Sep; 102(3):423-33. PubMed ID: 22691869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.